Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-05

Clinical Trial Update: Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting cefiderocol concentrations in the lungs of hospitalized patients with bacterial pneumonia; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefiderocol (cefiderocol)

Snippet

Sponsor: Shionogi | Conditions: Bacterial Pneumonia | Phase 1 | Status: TERMINATED | Results posted: 2020-11-05